ArticleGynecologic oncology research and practice2014

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines.

Micael Lopez-Acevedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.